Assyro AI

Orange Book product · Generic (ANDA)

HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

HEPARIN SODIUM

Generic (ANDA)ANDA 212441TE APRX FRESENIUS KABI USA

At a glance

Jul 24, 2020

Approved

Generic (ANDA)

Application

AP

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jul 24, 2020

    6 yr ago

  2. Today

Pharmaceutical detail

Active ingredient

HEPARIN SODIUM

Strength

200 UNITS/100ML

Dosage form

INJECTABLE

Route

INJECTION

TE code

AP

Application

ANDA 212441

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of HEPARIN SODIUM

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.